"We expect valuations to improve post-2005"

Smart Talk

 The Rs 233-crore Elder Pharmaceuticals is one of the fastest-growing pharmaceutical companies in India. The company expects its top brands to grow 40-45 cent in FY04. It posted a total income of Rs 60.94 crore for the first quarter of the current fiscal, per cent.

 

 The company almost doubled its gross profit to Rs 5.14 crore (against Rs 2.66 crore), while the net profit improved to Rs 3.04 crore (Rs 1.30 crore).

 

 The scrip is currently trading at Rs 70 levels, a P/E of 10x. Alok Saxena, director (international division), talks about the company